Ro KhannaSell
PFE Common Stock · Transaction Jun 16, 2026 · Filed Jul 6, 2026 · Amount pending receipt enrichment
NEW YORK STOCK EXCHANGE, INC. · PFE
+0.61% · +$0.1500 · Vol 38.4M
Market closed · last close 4:00 PM ET · price as of 19:54:55 ET
Pfizer Inc
Pharmaceuticals
$24.69
Veridion Score
BETAHIGH CONF · 6/6 factorsMon Jul 27 · market closed · Markets closed · resumes Tue 9:30 ET · PFE
MethodologyPFE
Pfizer Inc
Mon Jul 27 · market closed · Markets closed · resumes Tue 9:30 ET
BUY BIAS
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
64/ 100
Veridion Score
BUY BIAS · HIGH confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Mon Jul 27 · market closed · Markets closed · resumes Tue 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is PFE moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Pfizer Inc
PHARMACEUTICAL PREPARATIONSListed since
1951
Employees
75K
Country
US
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$24.57
Day high
$24.88
Day low
$24.44
Previous close
$24.54
52W high
$28.55
-13.52% from high
52W low
$23.29
27% of range
Market cap
$139.9B
P/E
11.65×
EPS
$2.12
Beta
0.11
Shares out
5.7B
Volume
38.4M
0.82× rel vol
Avg volume
46.8M
VWAP
$24.72
Price history computed in-house
1W
-1.00%
1M
+1.65%
3M
-5.98%
1Y
+1.56%
YTD
-0.84%
SMA 50 $25.12 · below
SMA 200 $25.83 · below
52W position 27%
PFE overview
Veridion Score
64
6 of 6 factors measured
Congress receipts
5
Ro Khanna · Sale
13F holders
1
Scion Asset Management
Receipt-backed holder profiles
Related filings and maps
Public disclosures
Congress activity in PFE
Official filing ↗
Ro KhannaSell
PFE Common Stock · Transaction Jun 2, 2026 · Filed Jul 6, 2026 · Amount pending receipt enrichment
Ro KhannaBuy
PFE Common Stock · Transaction May 15, 2026 · Filed Jun 9, 2026 · Amount pending receipt enrichment
Ro KhannaBuy
PFE Common Stock · Transaction Apr 13, 2026 · Filed May 11, 2026 · Amount pending receipt enrichment
Gilbert CisnerosSell
PFE · Transaction Mar 13, 2026 · Filed Apr 7, 2026 · $1,001 to $15,000
Federal contracts
PFE contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for PFE in this window.
Lobbying spend
PFE lobbying filings, year to date.
Registered lobbying filings matched to Pfizer Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for PFE in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for PFE.
Options
Sovereign unlock shows live options positioning for PFE.